HRP20000171B1 - Oral compositions of levosimendan - Google Patents
Oral compositions of levosimendanInfo
- Publication number
- HRP20000171B1 HRP20000171B1 HR20000171A HRP20000171A HRP20000171B1 HR P20000171 B1 HRP20000171 B1 HR P20000171B1 HR 20000171 A HR20000171 A HR 20000171A HR P20000171 A HRP20000171 A HR P20000171A HR P20000171 B1 HRP20000171 B1 HR P20000171B1
- Authority
- HR
- Croatia
- Prior art keywords
- levosimendan
- oral compositions
- polymorphic form
- crystalline polymorphic
- demands
- Prior art date
Links
- WHXMKTBCFHIYNQ-SECBINFHSA-N levosimendan Chemical compound C[C@@H]1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1 WHXMKTBCFHIYNQ-SECBINFHSA-N 0.000 title abstract 3
- 229960000692 levosimendan Drugs 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000000634 powder X-ray diffraction Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI973804A FI973804A (fi) | 1997-09-26 | 1997-09-26 | Levosimendaanin oraalisia koostumuksia |
PCT/FI1998/000753 WO1999016443A1 (en) | 1997-09-26 | 1998-09-24 | Oral compositions of levosimendan |
Publications (2)
Publication Number | Publication Date |
---|---|
HRP20000171A2 HRP20000171A2 (en) | 2000-12-31 |
HRP20000171B1 true HRP20000171B1 (en) | 2009-06-30 |
Family
ID=8549609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20000171A HRP20000171B1 (en) | 1997-09-26 | 2000-03-23 | Oral compositions of levosimendan |
Country Status (36)
Country | Link |
---|---|
US (1) | US6355269B1 (xx) |
EP (1) | EP1014987B1 (xx) |
JP (1) | JP4493840B2 (xx) |
KR (1) | KR100762022B1 (xx) |
CN (1) | CN1149994C (xx) |
AR (1) | AR013519A1 (xx) |
AT (1) | ATE260659T1 (xx) |
AU (1) | AU732489B2 (xx) |
BG (1) | BG64746B1 (xx) |
BR (1) | BR9813213A (xx) |
CA (1) | CA2304702C (xx) |
CZ (1) | CZ294984B6 (xx) |
DE (1) | DE69822172T2 (xx) |
DK (1) | DK1014987T3 (xx) |
EA (1) | EA001647B1 (xx) |
EE (1) | EE03854B1 (xx) |
ES (1) | ES2217580T3 (xx) |
FI (1) | FI973804A (xx) |
GE (1) | GEP20032943B (xx) |
HK (1) | HK1032001A1 (xx) |
HR (1) | HRP20000171B1 (xx) |
HU (1) | HUP0003757A3 (xx) |
ID (1) | ID24486A (xx) |
IL (1) | IL134802A (xx) |
MX (1) | MXPA00002956A (xx) |
MY (1) | MY118156A (xx) |
NO (1) | NO320047B1 (xx) |
NZ (1) | NZ503207A (xx) |
PL (1) | PL190862B1 (xx) |
PT (1) | PT1014987E (xx) |
RS (1) | RS49708B (xx) |
SI (1) | SI1014987T1 (xx) |
SK (1) | SK283187B6 (xx) |
TR (1) | TR200000635T2 (xx) |
WO (1) | WO1999016443A1 (xx) |
YU (1) | YU17700A (xx) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9606474D0 (en) * | 1996-03-27 | 1996-06-05 | Orion Yhytmo Oy | Method for obtaining pure enantiomers of a pyridazinone derivative |
FI980901A (fi) * | 1998-04-23 | 1999-10-24 | Orion Yhtymae Oyj | Levosimendaania säädellysti vapauttavia oraalisia koostumuksia |
FI980902A (fi) * | 1998-04-23 | 1999-10-24 | Orion Yhtymae Oyj | Levosimendaanin stabiileja koostumuksia |
FI20000577A0 (fi) * | 2000-03-13 | 2000-03-13 | Orion Yhtymae Oy | Pyridatsinyylifenyylihydratsoneja |
US8067032B2 (en) | 2000-12-22 | 2011-11-29 | Baxter International Inc. | Method for preparing submicron particles of antineoplastic agents |
US9700866B2 (en) | 2000-12-22 | 2017-07-11 | Baxter International Inc. | Surfactant systems for delivery of organic compounds |
DK1347747T3 (da) * | 2000-12-22 | 2006-04-10 | Baxter Int | Fremgangsmåde til behandling af submikropartikelsuspensioner af farmaceutiske midler |
FI20010233A0 (fi) * | 2001-02-08 | 2001-02-08 | Orion Corp | Menetelmä sydämen vajaatoiminnan hoitoon |
FI20011465A0 (fi) * | 2001-07-04 | 2001-07-04 | Orion Corp | Pyridatsinonijohdannaisen uusi käyttö |
JP2005504090A (ja) | 2001-09-26 | 2005-02-10 | バクスター・インターナショナル・インコーポレイテッド | 分散体および溶媒相または液相の除去によるサブミクロンサイズ−ナノ粒子の調製 |
US20060003012A9 (en) | 2001-09-26 | 2006-01-05 | Sean Brynjelsen | Preparation of submicron solid particle suspensions by sonication of multiphase systems |
CN100428937C (zh) * | 2003-10-30 | 2008-10-29 | 北京海合天科技开发有限公司 | 左西孟旦冷冻干燥组合物 |
EP2454241B1 (en) | 2009-07-14 | 2014-04-02 | Cipla Limited | Process for preparing levosimendan and intermediates for use in the process |
CN104418810A (zh) * | 2013-09-04 | 2015-03-18 | 北京博时安泰科技发展有限公司 | 一种左西孟旦的合成新路线 |
CN103554032A (zh) * | 2013-11-12 | 2014-02-05 | 江苏正大清江制药有限公司 | 高光学纯度(-)-6-(4-氨基苯基)-4,5-二氢-5-甲基-3(2h)-哒嗪酮的制备方法 |
ITMI20132185A1 (it) * | 2013-12-23 | 2015-06-24 | Edmond Pharma Srl | Polimorfi di levosimendan |
CN104987310A (zh) * | 2015-06-03 | 2015-10-21 | 青岛农业大学 | 左西孟旦的合成工艺 |
CN111474289A (zh) * | 2019-10-31 | 2020-07-31 | 武汉嘉诺康医药技术有限公司 | 一种利用反相色谱分离分析左西孟旦中右西孟旦的方法 |
EP4076398A4 (en) * | 2019-12-16 | 2024-01-03 | Tenax Therapeutics, Inc. | LEVOSIMENDAN TO TREAT PULMONARY HYPERTENSION ACCOMPANIED BY HEART FAILURE BY MEANS OF PRESERVED EJECTION FRACTION (PH-HF-PEF) |
CN111548310B (zh) * | 2020-05-12 | 2021-07-02 | 成都欣捷高新技术开发股份有限公司 | 一种左西孟旦钠晶型及其制备方法 |
CN111718299B (zh) * | 2020-07-23 | 2023-03-10 | 成都欣捷高新技术开发股份有限公司 | 一种左西孟旦钠晶型b及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0383449A2 (en) * | 1989-02-11 | 1990-08-22 | Orion-Yhtymà Oy | Pyridazinone derivatives and processes for preparing the same |
WO1992012135A1 (en) * | 1991-01-03 | 1992-07-23 | Orion-Yhtymä Oy | (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-hydrazono]propanedinitrile |
WO1993021921A1 (en) * | 1992-05-06 | 1993-11-11 | Orion-Yhtymä Oy | Anti-ischemic medicament |
WO1997035841A2 (en) * | 1996-03-27 | 1997-10-02 | Orion-Yhtymä Oy | Method for obtaining pure enantiomers of a pyridazinone derivative |
WO1998001111A1 (en) * | 1996-07-05 | 1998-01-15 | Orion-Yhtymä Oy | Transdermal compositions containing levosimendan |
-
1997
- 1997-09-26 FI FI973804A patent/FI973804A/fi not_active Application Discontinuation
-
1998
- 1998-09-21 MY MYPI98004329A patent/MY118156A/en unknown
- 1998-09-24 EE EEP200000187A patent/EE03854B1/xx not_active IP Right Cessation
- 1998-09-24 AU AU93506/98A patent/AU732489B2/en not_active Ceased
- 1998-09-24 JP JP2000513579A patent/JP4493840B2/ja not_active Expired - Fee Related
- 1998-09-24 ES ES98946480T patent/ES2217580T3/es not_active Expired - Lifetime
- 1998-09-24 AR ARP980104780A patent/AR013519A1/es active IP Right Grant
- 1998-09-24 WO PCT/FI1998/000753 patent/WO1999016443A1/en not_active Application Discontinuation
- 1998-09-24 TR TR2000/00635T patent/TR200000635T2/xx unknown
- 1998-09-24 KR KR1020007003095A patent/KR100762022B1/ko not_active IP Right Cessation
- 1998-09-24 NZ NZ503207A patent/NZ503207A/en unknown
- 1998-09-24 DK DK98946480T patent/DK1014987T3/da active
- 1998-09-24 CA CA002304702A patent/CA2304702C/en not_active Expired - Fee Related
- 1998-09-24 DE DE69822172T patent/DE69822172T2/de not_active Expired - Lifetime
- 1998-09-24 US US09/509,205 patent/US6355269B1/en not_active Expired - Fee Related
- 1998-09-24 HU HU0003757A patent/HUP0003757A3/hu unknown
- 1998-09-24 CN CNB988094673A patent/CN1149994C/zh not_active Expired - Fee Related
- 1998-09-24 BR BR9813213-0A patent/BR9813213A/pt not_active Application Discontinuation
- 1998-09-24 ID IDW20000565A patent/ID24486A/id unknown
- 1998-09-24 EA EA200000360A patent/EA001647B1/ru not_active IP Right Cessation
- 1998-09-24 AT AT98946480T patent/ATE260659T1/de active
- 1998-09-24 MX MXPA00002956A patent/MXPA00002956A/es not_active IP Right Cessation
- 1998-09-24 SI SI9830645T patent/SI1014987T1/xx unknown
- 1998-09-24 CZ CZ2000919A patent/CZ294984B6/cs not_active IP Right Cessation
- 1998-09-24 IL IL13480298A patent/IL134802A/en not_active IP Right Cessation
- 1998-09-24 EP EP98946480A patent/EP1014987B1/en not_active Expired - Lifetime
- 1998-09-24 GE GEAP19985319A patent/GEP20032943B/en unknown
- 1998-09-24 PL PL339461A patent/PL190862B1/pl not_active IP Right Cessation
- 1998-09-24 SK SK384-2000A patent/SK283187B6/sk not_active IP Right Cessation
- 1998-09-24 PT PT98946480T patent/PT1014987E/pt unknown
- 1998-09-24 RS YUP-177/00A patent/RS49708B/sr unknown
-
2000
- 2000-03-16 BG BG104250A patent/BG64746B1/bg unknown
- 2000-03-23 HR HR20000171A patent/HRP20000171B1/xx not_active IP Right Cessation
- 2000-03-24 YU YU17700A patent/YU17700A/sh unknown
- 2000-03-27 NO NO20001585A patent/NO320047B1/no not_active IP Right Cessation
-
2001
- 2001-04-10 HK HK01102520A patent/HK1032001A1/xx not_active IP Right Cessation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0383449A2 (en) * | 1989-02-11 | 1990-08-22 | Orion-Yhtymà Oy | Pyridazinone derivatives and processes for preparing the same |
WO1992012135A1 (en) * | 1991-01-03 | 1992-07-23 | Orion-Yhtymä Oy | (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-hydrazono]propanedinitrile |
WO1993021921A1 (en) * | 1992-05-06 | 1993-11-11 | Orion-Yhtymä Oy | Anti-ischemic medicament |
WO1997035841A2 (en) * | 1996-03-27 | 1997-10-02 | Orion-Yhtymä Oy | Method for obtaining pure enantiomers of a pyridazinone derivative |
WO1998001111A1 (en) * | 1996-07-05 | 1998-01-15 | Orion-Yhtymä Oy | Transdermal compositions containing levosimendan |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20000171B1 (en) | Oral compositions of levosimendan | |
AU4264396A (en) | Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof | |
BG105564A (en) | Galantamine-containing composition with controlled release | |
HUP9802822A3 (en) | Halobenzimidazol derivatives, intermediates, preparation thereof and microbocide compositions containing these compounds as active ingredients | |
MX9800125A (es) | Nuevas composiciones medicinales estables para generar aerosoles libres de gas propulsor. | |
DE69705300T2 (de) | Cyclopropylalkansäurederivate | |
CA2049085A1 (en) | Oral compositions containing stabilized copper | |
ES8801277A1 (es) | Procedimiento para preparar (1,2,4) triazolo (1,5-c) quinazolinas | |
BG103947A (en) | Derivatives of 9-oxymerythromycin | |
RS51541B (sr) | 5-hloro-3-(4-metansulfonilfenil)-6'-metil-/2,3'/bipiridinil u čistom kristalnom obliku i postupak sinteze | |
SI1121127T1 (en) | Oral pharmaceutical compositions containing buprenorphin | |
HUP9802533A2 (hu) | 3-6 Szénatomos alkolholt tartalmazó antimikrobiális szájápoló készítmények | |
HK1039273A1 (en) | Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient | |
HUP9900365A3 (en) | N-aryl-1,2,4-triazolin-5-on derivatives, preparation and use thereof, insecticide, arachnicide and nematocide compositions containing these compounds as active ingredients | |
IT1243193B (it) | Composizioni farmaceutiche orali a base di melatonina | |
GEP20043365B (en) | Polymorphic Salt | |
MD502F1 (en) | New adenozin derivatives, method for preparation, pharmaceutical baze compositions | |
HU9600360D0 (en) | New bis-naphthalimides for the treatment of cancer | |
IL112999A0 (en) | Crystalline salts of 2,3,4,5- tetrahydro -1h-3-benzazepine compounds, their preparation and pharmaceutical compositions containing them | |
HK1005454A1 (en) | Pure crystalline form of refapentine | |
TW252979B (xx) | ||
IL114968A (en) | 1,4-dihydropyridine compounds and pharmaceutical compositions containing them | |
GR3017348T3 (en) | Novel isoindolinone derivative, preparation thereof, and pharmaceutical compositions containing same. | |
HRP20000704B1 (en) | Controlled release peroral compositions of levosimendan | |
EP0717618A4 (en) | STABILIZED FORMULATION FOR TABLETS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
B1PR | Patent granted | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20100827 Year of fee payment: 13 |
|
PBON | Lapse due to non-payment of renewal fee |
Effective date: 20110925 |